Severity
Critical
FDA Drug recall · Reported December 25, 2013
Marketed without an Approved NDA/ANDA: product found to contain undeclared sildenafil
Fabscout Entertainment, Inc recalled Evil Root 1200 mg, supplied in 6 capsules per bottle, Manufacturer: Tibet Shengyang Healt… - a critical-severity action.
Evil Root 1200 mg, supplied in 6 capsules per bottle, Manufacturer: Tibet Shengyang Healt… was recalled by Fabscout Entertainment, Inc in December 25, 2013. Reason: Marketed without an Approved NDA/ANDA: product found to contain undeclared sildenafil. Check the official notice for the remedy. Verify recall #D-376-2014 with the FDA Drug before acting.
The recall
Fabscout Entertainment, Inc issued this critical-severity FDA Drug recall-Marketed without an Approved NDA/ANDA: product found to contain undeclared sildenafil.
Sourced from official FDA Drug enforcement records. Verify recall #D-376-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-376-2014) was formally reported on December 25, 2013, with the manufacturer initiating the action on August 14, 2013. It is classified under Critical severity (Class I), with a current status of Terminated. Fabscout Entertainment, Inc is listed as the recalling firm, operating out of Ft Lauderdale, FL. Federal records list the affected scope as 32 bottles of 6 capsules each.
The documented reason for this recall is: Marketed without an Approved NDA/ANDA: product found to contain undeclared sildenafil Distribution data in the federal record shows the product reached: CA, FL and UT. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 3,731 children & baby products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
32 bottles of 6 capsules each
Related Recalls
6
0 from same agency
Evil Root 1200 mg, supplied in 6 capsules per bottle, Manufacturer: Tibet Shengyang Health Medicine Co.,Ltd. Address: No. 98, Min zu Road, Lhasa
Marketed without an Approved NDA/ANDA: product found to contain undeclared sildenafil
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-376-2014 |
| Date reported | December 25, 2013 |
| Date initiated | August 14, 2013 |
| Recalling firm | Fabscout Entertainment, Inc |
| Firm location | Ft Lauderdale, FL |
| Affected scope | 32 bottles of 6 capsules each |
| Distribution | CA, FL and UT |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Xishentang Dongguan Trading Co, Ltd., dba Pretty-Life, of China · 2026-07-02
Diamond Wipes International, Inc. of Chino, California · 2026-07-02
· 2026-07-02
· 2026-07-02
Sanven Technology Ltd., dba Vevor, of Rancho Cucamonga, California · 2026-07-02
Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 25, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.